The Latest

The CEO of WINFertility and medical director at CCRM Fertility Houston explain why strong fertility benefits are vital to an organization's success.

John Mellor, the CEO of Domo, explains how bad tech is costing companies $6.5 billion in weekly productivity.

Applications for U.S. unemployment benefits eased last week and a measure of labor costs remained firm in the closing months of 2022.

It's on people practitioners to give those early in their careers the same meaningful development opportunities we were afforded in our own careers, reinvented in the context of hybrid work.

The free market must encourage higher cost providers to lower their prices, or those with poorer outcomes to improve by adopting best practices.

By incorporating company values with benefit offerings, organizations can create a more powerful impact on potential and current employees.

Our third annual celebration will recognize industry leaders across the HR and benefits spaces. Who deserves a nod?

Amy Halliburton recently joined the insurance company as their new chief human resource officer. She shares her plans for the role and the biggest challenges for HR in 2023.

The list price for non-branded Insulin Lispro Injection will be cut to $25 a vial in May, while some Humalog and Humulin doses will be slashed 70% in the fourth quarter.

Massive amounts of visual information can be leveraged to lower risk and workers' comp costs, as well as build a culture of caring.